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Abstract
Background: Electronic medical records contain valuable clinical information not readily available elsewhere.
Accordingly, they hold important potential for contributing to and enhancing chronic disease registries with the
goal of improving chronic disease management; however a standard for diagnoses of conditions such as diabetes
remains to be developed. The purpose of this study was to establish a validated electronic medical record
definition for diabetes.
Methods: We constructed a retrospective cohort using health administrative data from the Institute for Clinical
Evaluative Sciences Ontario Diabetes Database linked with electronic medical records from the Deliver Primary
Healthcare Information Project using data from 1 April 2006 - 31 March 2008 (N = 19,443). We systematically
examined eight definitions for diabetes diagnosis, both established and proposed.
Results: The definition that identified the highest number of patients with diabetes (N = 2,180) while limiting to
those with the highest probability of having diabetes was: individuals with ≥2 abnormal plasma glucose tests, or
diabetes on the problem list, or insulin prescription, or ≥2 oral anti-diabetic agents, or HbA1c ≥6.5%. Compared to
the Ontario Diabetes Database, this definition identified 13% more patients while maintaining good sensitivity
(75%) and specificity (98%).
Conclusions: This study establishes the feasibility of developing an electronic medical record standard definition of
diabetes and validates an algorithm for use in this context. While the algorithm may need to be tailored to fit
available data in different electronic medical records, it contributes to the establishment of validated disease
registries with the goal of enhancing research, and enabling quality improvement in clinical care and patient self-
management.
Background
Diabetes is a significant and costly disease that is pro-
jected to affect 438 million individuals worldwide by the
year 2030 [1]. The burden of diabetes lies not only in the
absolute number of individuals with the disease, but in
the severe complications associated with unmanaged dia-
betes. In Canada, it is estimated that 3-5% of the
population may have undiagnosed diabetes [2,3], and
Ontario has seen minimal progress in reducing the rates
of complications due to the disease [4]. Therefore, a criti-
cal need exists in our healthcare system to efficiently
diagnose and effectively manage patients with diabetes.
Lack of available data systems for clinical use and quality
improvement is a major barrier to achieving this goal.
There is a significant effort in Canada and the United
States towards the uptake of electronic medical records
(EMRs) in an effort to obtain the benefits of a compu-
terized health care system [5]. EMRs are designed to
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past research has demonstrated the benefits of pairing
an electronic medical system with disease registries [6].
Diabetes registries offer users a quick and efficient way
to identify high-risk patients and measure clinical out-
comes, with potential to improve care both at the physi-
cian level with adherence to clinical practice guidelines,
and the patient level, with self-management and
improved medication adherence. However, the ability to
accurately identify those individuals diagnosed with the
disease remains a critical feature of any successful
chronic disease registry, and a crucial first step for con-
verting an EMR into a researchable database to measure
and address quality of care [7,8]. Currently, many juris-
dictions in North America lack both wide adoption of
EMRs and validated chronic disease registries. One
approach to understanding the prevalence and burden
of disease due to diabetes has been the use of the Uni-
ted States Department of Veterans Affairs, or Canada’s
National Diabetes Surveillance System (NDSS), both
based on administrative claims [9,10]. The Ontario,
Canada version of this approach is known as the
Ontario Diabetes Database (ODD), a de-identified listing
of those with diabetes among all those eligible for health
care in this universal health insurance system. The ODD
excludes people with gestational diabetes and does not
distinguish between type 1 and type 2 diabetes. Based
on a validated algorithm against primary care chart data
in 1998, the ODD exhibited a high level of sensitivity
and specificity (86 percent and 97 percent, respectively)
w i t hap o s i t i v ep r e d i c t i v ev a l u eo f8 0 % ,a n dt h u sh a s
been a valuable tool for surveillance purposes [11].
However, administrative data often lack clinical details
such as test results and medications, limiting their use-
fulness for improving clinical care.
EMR data generally contain rich clinical detail and
therefore hold the promise of being used to understand
and improve processes of care and their outcomes. A
validated EMR approach to identify people with diabetes
is therefore needed. The primary objective of this
research was to assess the feasibility and performance of
an EMR definition of diabetes by developing EMR
approaches to defining diabetes and comparing these
approaches to the ODD.
Methods
Study Database and Population
A retrospective cohort was constructed using the ODD
linked with EMR data from the Deliver Primary Health-
care Information (DELPHI) Project [12]. The target
practice population of EMR data included all practices
enrolled in the DELPHI Project. The DELPHI database
is based at the Centre for Studies in Family Medicine at
The University of Western Ontario and is a researchable
database established in 2005. The database is populated
with de-identified electronic health records of 22 family
practitioners and their patients in Southwestern Ontario,
including both rural and urban practices, and is inclu-
sive of all patients in the practice. The DELPHI database
consists of patient medical records entered into
HealthScreen™, one of the electronic medical record
software programs used in Ontario. The database was
created by pooling the de-identified health records of
patients using data from 1 April 2006 - 31 March 2008.
Using a common unique encrypted identifier, a data
linkage was performed between patients enrolled in the
DELPHI database prior to April 1, 2006 and the ODD
and Ontario’s health registry, the Registered Persons
Database, both held at the Institute for Clinical Evalua-
tive Sciences (N = 19,443).
Diabetes Definitions
A detailed description of each of the eight diabetes defi-
nitions is found in Table 1. A Base Definition (Defini-
tion 1) was selected based on its alignment with the
Canadian 2003 Clinical Practice Guideline (CPG) diag-
nostic glycemic values and types of medication pre-
scribed [13]. From the Base Definition, a series of five
permutations (Definition 1.a. - 1.e.) were selected to
determine the most comprehensive EMR definition of
diabetes achievable. These permutations were systemati-
cally examined to determine the impact of the number
of oral anti-diabetic drugs prescribed and the number of
plasma glucose tests, as well as the clinically important
items of ‘diabetes on problem list’ and HbA1c ≥6.5%.
‘Diabetes on problem list’ is consistently used in the lit-
erature for capturing patients with diabetes [14] and was
manually reviewed by an expert source (one of the co-
authors; SH) to ensure coding accuracy and reliability of
diagnosis. Patients with gestational diabetes, prediabetes
and polycystic ovary syndrome (PCOS) were excluded
during the manual coding process. The HbA1c value of
6.5% was recently approved by the American Diabetes
Association as a screening test by an international com-
mittee of experts [15-19]. The remaining two diabetes
definitions included the definition proposed by the
Ontario Ministry of Health and Long-Term Care in
Ontario for the Baseline Diabetes Database Initiative
(BDDI) to populate a provincial diabetes registry (Defi-
nition 2), and the previously validated ODD definition
(Definition 3).
Analysis
To investigate variation in diabetes diagnosis, an analysis
using 2 × 2 factorials was conducted using the eight
varying definitions of diabetes. Sensitivity, specificity,
positive predictive value (PPV) and negative predictive
value (NPV) were calculated for each 2 × 2 factorial.
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“gold standard” condition to a test outcome, such that
each 2 × 2 factorial would assign one definition as the
“gold standard” and one definition as the test outcome.
Sensitivity and specificity were calculated as the propor-
tion of patients with diabetes identified by a test definition
who either had or did not have diabetes according to the
comparator “gold standard”. PPV and NPV were calcu-
lated as the proportion of patients diagnosed with or with-
out diabetes identified by the test definition and confirmed
by the comparator “gold standard” definition. Prevalence
estimates were calculated according to the number of
patients with diabetes identified by each definition. Statis-
tical analyses were performed using SAS 9.2 [20].
A s s u m i n gap r e v a l e n c eo fd i a b e t e so f8 . 8 %[ 2 1 ]a n d
based on the size of the patient population in the linked
EMR dataset, reasonably precise estimates of sensitivity
and specificity were ensured. For example, with 19,443
people in the dataset, 1,710 would be expected to have
diabetes and for an expected sensitivity of 80%, the 95%
confidence interval would be ± 1.9%. For an expected
specificity of 95%, the 95% confidence interval would be
± 0.3%. Our sample size was substantially larger than the
approximately 3000 charts used in an office-based valida-
tion of an administrative data algorithm for diabetes, and
therefore suitable for the purposes of this research [11].
Ethical Approval
Ethical approval for this study was obtained through the
ICES/Sunnybrook research ethics review as part of the
standard process. Ethical approval at The University of
Western Ontario was included under the ethically
approved umbrella of the DELPHI Project.
Results
The linked health administrative-EMR dataset included
22 family practitioners and 19,443 patients in
Southwestern Ontario. Physician demographics are pre-
sented in Table 2. Physician characteristics were similar
except that DELPHI physicians were more likely to be
based in a rural area.
Table 1 displays the diagnosed population by diabetes
definition. Crude prevalence rates varied by definition,
from 5.0% (Base Definition 1) to 12.0% (Definition 1.d./
1.e.).
Additional file 1 reports the sensitivity and specificity
analysis by diabetes definitions. The definition that iden-
tified the highest number of patients with diabetes while
a tt h es a m et i m el i m i t i n gt ot h o s ew i t ht h eh i g h e s t
probability of having diabetes was Definition 1.c. (N =
2,180). This definition identified 13% (N = 245) more
patients than the ODD definition while maintaining
good sensitivity (75%) and specificity (98%) in compari-
son with the ODD.
Both Definitions 1.d. and 1.e. (N = 2,329) identified
the highest number of patients with diabetes using a
broader definition, and identified 20% (N = 394) more
patients than the ODD definition while maintaining
good sensitivity (1.d. = 73%; 1.e. = 72%) and specificity
(1.d./1.e. = 99%) in comparison with the ODD.
The currently proposed diabetes definition for use in
the BDDI to pre-populate a diabetes registry missed
27% (N = 594) of those identified as having diabetes
when compared to our most comprehensive definition
Table 1 Number of patients diagnosed with diabetes (true positives between linked health administrative-EMR
dataset) and associated crude prevalence rates categorized by diabetes definition
Definition # Patients with
Diabetes
Crude
Prevalence %
1. Base Definition: ≥2 plasma glucose tests
a OR insulin OR ≥2 oral anti-diabetic drugs 975 5.0
a. Base OR HbA1c ≥6.5% 1515 7.8
b. Base OR diabetes on problem list 1905 9.8
c. Base OR HbA1c ≥6.5% OR diabetes on problem list 2180 11.2
d. Base OR HbA1c ≥6.5% OR diabetes on problem list; Limit base definition to ≥1 oral anti-
diabetic drugs
2329 12.0
e. Base OR HbA1c ≥6.5% OR diabetes on problem list; Limit base definition to ≥1 oral anti-
diabetic drugs OR ≥1 plasma glucose tests
2329 12.0
2. Registry: ≥2- ICD 250 codes AND ≥1 HbA1c lab value 1586 8.2
3. ODD: one hospitalization discharge with a diagnostic code for diabetes (ICD9 250) OR two
physician service claims with a diagnosis recorded for diabetes (ICD8 250) within a 2-year period
1935 10.0
aPlasma glucose tests include: fasting plasma glucose ≥ 7.0 mmol/L; casual plasma glucose ≥ 11.1 mmol/L; 2-hour plasma glucose in a 75-g oral glucose
tolerance test ≥ 11.1 mmol/L.
Table 2 Demographics of 22 DELPHI physicians
compared to physicians in the province of Ontario
DELPHI Ontario
a
N = 22 N = 11,819
Male (%) 68.0 61.7
Years since graduation 26.5 23.5
Rural (%) 55.0 10.1
aInstitute for Clinical Evaluative Sciences, August 2008.
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and specificity (98%) in comparison with the ODD.
Patient demographics are presented in Table 3.
Among patients in the linked dataset, 11.2% were found
to have diabetes using Definition 1.c. Patients with dia-
betes were slightly older and were much more likely to
have coronary artery disease, hypertension, and a posi-
tive family history of diabetes.
Discussion
Current literature suggests that large administrative
datasets lack precision and detail [14,22-25], and as the
clinical practice world progresses toward electronic
medical systems and chronic disease registries, there is a
clear need to validate a methodology for identifying
individuals with chronic diseases and specifically, dia-
betes. Our results support the ODD algorithm for dia-
betes diagnosis in administrative data, and suggest an
EMR standard for diagnosis of disease in the DELPHI
database using Definition 1.c. This definition clearly
aligns with the Canadian 2003 clinical practice guideline
diagnostic criteria as it incorporates two or more abnor-
mal plasma glucose tests, or the use of insulin, or two
or more oral antidiabetic drugs [13]. It also aligns with
clinically significant items including ‘diabetes on the
problem list’ [14] or having an HbA1c ≥6.5%. This
research supports the incorporation of HbA1c ≥6.5%, a
value recently approved by the American Diabetes Asso-
ciation to diagnose [15-19,26].
This research tested varying definitions in the assess-
ment of an EMR standard for diabetes diagnosis, some
established (for example, the Ontario Diabetes Database
definition) and some proposed (for example, the BDDI
established by the Ontario Ministry of Health and Long-
Term Care). We started with a Base Definition, and sys-
tematically examined a series of permutations to deter-
mine the most comprehensive EMR definition of
diabetes achievable. The EMR standard definition cre-
ated for this study identified more patients than the
ODD definition while maintaining good sensitivity and
specificity in comparison with the ODD, and repre-
sented the most comprehensive EMR definition of dia-
betes achievable in our data. Our findings also support
Definition 1.d. as an alternative EMR diabetes diagnosis,
representing a 7% increase from our EMR standard.
Clinically, patients on one or more oral anti-diabetic
agents (when compared to two or more in our EMR
standard) could have polycystic ovarian syndrome
(PCOS) or pre-diabetes; therefore Definition 1.d. should
only be used when the critical first step is taken of
Table 3 Characteristics of 19442a patients identified in the EMR database between 1 April 2006 - 31 March 2008,
stratified by diabetes diagnosis and sex
Overall Men Women
% (unless otherwise indicated) General
N = 19442
a
DM
b
N = 2180
Non-DM N = 17262 DM
b
N = 1174
Non-DM
N = 7868
DM
b
N = 1006
Non-DM
N = 9394
Males 46.5 53.9 45.6
Age (Mean) 42.5 45.0 42.5
Rurality 44.0 46.1 43.7 46.4 43.3 45.7 44.1
New Immigrant
c 0.4 0.6 0.4 0.7 0.5 0.0 0.4
Income
Quintile 1-low 9.7 10.9 9.5 10.4 9.3 11.5 9.7
Quintile 5-high 32.0 30.6 32.2 30.3 32.2 31.0 32.1
Diagnoses
Diabetes on problem list 8.5 75.8 0.0 73.3 0.0 78.7 0.0
Diabetes complication problem list
d 25.5 61.7 20.9 61.6 21.4 61.7 20.5
Polycystic ovary syndrome (PCOS) 0.1 0.0 0.1 0.0 0.0 0.4 0.2
Coronary Artery Disease (CAD) 4.7 14.0 3.5 16.7 4.6 11.0 2.6
Hypertension 16.5 43.0 13.2 42.2 12.3 44.0 13.9
Family History of Diabetes 6.8 14.2 5.9 9.9 4.2 19.2 7.2
Visits to Family Physician (Mean) 8.4 11.5 7.9 10.7 7.2 12.4 8.4
Prescribed Diabetes Medications
e
Insulin Ever 1.7 15.4 0.0 16.1 0.0 14.6 0.0
Metformin Ever 6.6 52.9 0.7 53.9 0. 8 51.8 0.6
Oral hypoglycemic agents 4.7 40.4 0.1 42.3 0.0 38.1 0.2
aDemographics missing for 1 patient;
bDiabetes diagnosis using Definition 1.c.
cNew immigrant - patients not eligible for provincial health insurance (OHIP) as of the study start date used as proxy to determine new immigrant status;
dDiabetes related complication including: coronary artery disease, hypertension, chronic obstructive pulmonary disease, polycystic ovarian syndrome,
dyslipidemia, stroke/transient ischemic attack, erectile dysfunction, cardiovascular disease;
eOver a 2 year time period.
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definition can be recommended in EMRs that reliably
identify PCOS and pre-diabetes or when these condi-
tions can otherwise be excluded.
Health administrative and EMR data serve as valuable
tools in the ongoing surveillance of disease, with EMRs
offering an added advantage of patient level process and
outcome measures. Furthermore, EMRs have the poten-
tial of identifying unbiased diabetes incident cases, a
measure that can be challenging when using administra-
tive data solely as the data source [22,27]. Improving
case identification using administrative or EMR datasets
points to the need for continued linkages between these
types of databases, with a goal to improving the perfor-
mance of both and establishing validated disease regis-
tries [22,28].
The majority of Canadians with diabetes are managed
in the family practice setting [29], and the process of
populating a diabetes registry through the adoption of
an EMR provides access to a valuable resource of clini-
cal information that is not readily available elsewhere.
Diabetes registries offer users a quick and efficient way
to identify high-risk patients and measure clinical out-
comes, two critical first steps in the ongoing surveillance
of diabetes for clinicians, researchers and policy makers;
however the ability to accurately identify those indivi-
duals diagnosed with the disease remains a critical fea-
ture of any successful chronic disease registry [7,8].
It is important to acknowledge a number of limita-
tions in this research. Firstly, the DELPHI dataset does
not include consult letters or visit notes, valuable deter-
minants of diagnosis used in previous literature.
Although it is not possible to assess false positives in
the dataset, this method does shed light on the propor-
tion of people with diabetes missing. A second limita-
tion is that the DELPHI dataset is not population-based;
however it does represent all patients from a variety of
different types of practices and settings throughout
Southwestern Ontario that do not differ significantly
from Ontario physicians on the whole (with the excep-
tion of rurality identified in the results). Our findings
reveal slightly higher diabetes rates in the DELPHI
population (11.2% crude prevalence rate using our EMR
standard; 10.0% crude prevalence rate using ODD Defi-
nition) when compared to the most recent ICES 2004/
05 diabetes rate for Southwestern Ontario of 7.8% [30]
or Ontario rate of 8.8% [21]; however this is a popula-
tion receiving active medical care so rates are likely
higher when compared to the general population. A
third limitation to this research that is inherent in both
health administrative data and EMRs is a bias towards
individuals who use health services; therefore, our data-
set would only include those individuals receiving medi-
cal care. Furthermore, patients who migrate between
clinicians may contribute to under-reporting because no
one clinician record would be representative of the
delivery of care to those patients. Lastly, based on the
limitations of provincial billing codes, the ODD cannot
distinguish between type 1 and type 2 diabetes mellitus.
Type 2 diabetes accounts for 90-95% of the diagnosed
population and therefore we are confident that the
results of this study can be applied for determining type
2 diabetes diagnosis in the adult population [31].
Conclusions
This research investigated the concordance in diabetes
diagnosis between health administrative and EMR data-
bases as a first step in developing and validating an
EMR definition of diabetes. This study establishes a new
EMR standard definition of diabetes (individuals with ≥2
abnormal plasma glucose tests, or diabetes on the pro-
blem list, or insulin prescription, or ≥2 oral anti-diabetic
agents, or HbA1c ≥6.5%) and provides an alternative
definition, depending on the completeness of EMR diag-
noses. While this definition should be tested in other
EMR systems, it is a promising first step in using EMR-
based data to improve diabetes care. Future pursuit of a
diabetes registry will benefit from a comprehensive
understanding of the challenges of diabetes diagnosis
using electronic medical records, and holds important
potential for contributing to and enhancing chronic
disease registries with the goal of improving chronic
disease management and health outcomes.
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Additional file 1: Validation results for identifying patients with
diabetes using a linked health administrative-EMR dataset, between
1 April 2006 - 31 March 2008. Sensitivity, specificity, positive predictive
value, negative predictive value and kappa results for identifying patients
with diabetes based on 2 × 2 factorial analysis of 8 varying diagnosis
definitions.
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